MedTrace Logo

GAS5 Gene Expression and IL-6 in Rheumatoid Arthritis

NCT07796841 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2026-09-01

No results posted yet for this study

Summary

This study aims to investigate the expression of Growth Arrest-Specific 5 (GAS5) , a long non-coding RNA , in patients with Rheumatoid Arthritis compared with healthy individuals. The study will also assess the level of Interlukin-6 (IL-6) in the blood and explore the relationship between GAS5 expression and IL-6 levels in Rheumatoid Arthritis

Conditions

  • RA - Rheumatoid Arthritis

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Samar Mohamed Abozaid, Biochemistry demonstrator · Faculty of Medicine , Sohag University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-10-01
Primary Completion
2027-10-01
Completion
2027-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07796841 on ClinicalTrials.gov